Related Experiment Videos
Anti-obesity drug development
1L-MARC Research Center, Louisville, Kentucky 40213, USA.
Abstract:
Obesity accelerates morbidity and mortality and has been described by the World Health Organization (WHO) as an epidemic in many industrialised nations [101,102]. Diet, exercise and lifestyle recommendations have proven to be mostly ineffective in adequately preventing or treating the progression of this public health disease. Existing drug treatment is limited by the scarce number of safe and well-tolerated drugs with proven long-term efficacy in maintaining weight loss. Numerous anti-obesity drugs in development have promise. Yet, despite that obesity is the single most common nutritional problem in many developed nations and despite the devastating health consequences of this unchecked epidemic, investigational anti-obesity drugs face unique and significant challenges due to past and current experiences with anti-obesity drugs. It is anticipated that new anti-obesity drugs for this serious, multifaceted metabolic disease will become as safe and effective and as medically accepted as the treatment of other metabolic disorders such as hypertension, dyslipidaemia or Type 2 diabetes mellitus. This may be particularly important, given that these metabolic disorders may be largely due to or exacerbated by obesity itself.
Insights
Obesity is a growing epidemic, and current treatments are insufficient. New anti-obesity drugs are needed to safely and effectively manage this complex metabolic disease.
Area of Science:
- Metabolic disease research
- Public health and epidemiology
Background:
- Obesity is a global epidemic accelerating morbidity and mortality.
- Current lifestyle interventions are largely ineffective for obesity treatment.
- Limited availability of safe, effective, and well-tolerated anti-obesity medications.
Purpose of the Study:
- To review the challenges and promise of developing new anti-obesity drugs.
- To highlight the need for safe and effective pharmacological interventions for obesity management.
Main Methods:
- Review of existing literature on obesity and anti-obesity drug development.
- Analysis of challenges faced by investigational anti-obesity medications.
- Discussion of the potential for future anti-obesity drugs.
Main Results:
- Despite significant health consequences, developing effective anti-obesity drugs faces unique challenges.
- Numerous anti-obesity drugs are currently in development with promising potential.
- Obesity exacerbates other metabolic disorders like hypertension and diabetes.
Conclusions:
- New anti-obesity drugs are anticipated to become as safe and effective as treatments for other metabolic disorders.
- Addressing obesity is crucial for managing related metabolic conditions.
- Advancements in anti-obesity pharmacotherapy are essential for public health.